DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE
DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE
批准号:
9888324
负责人:
DAVID S STEPHENS
金额:
$16.41万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-06 至 2022-02-28
关键词:
AddressAntibiotic ResistanceAntibioticsCenters for Disease Control and Prevention (U.S.)Cessation of lifeChildChromosomesClinicalClonal ExpansionCompetenceComplexDNADNA TransposonsDataElementsEngineeringEnvironmentEpidemiologyEpithelialEpitheliumFrequenciesGene TransferGeneticGenetic DeterminismGenetic RecombinationGenomeGenomicsHigh PrevalenceHot SpotHumanIndividualInterventionInvestigationMacrolide-resistanceMacrolidesMediatingMicrobial BiofilmsMobile Genetic ElementsMolecularMovementMulti-Drug ResistanceNasopharynxNaturePneumococcal InfectionsPopulationPrevalenceProteinsRecombinantsResistanceRibosomesSerotypingSiteSourceStreptococcus pneumoniaeSurfaceVirulentWorld Health Organizationclinically relevantdesignearly childhoodemerging antimicrobial resistanceepidemiology studygenomic locushuman modelinsightmutantnovelpathogenpressurepriority pathogenrecombinaserespiratorytRNA Methyltransferases
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Streptococcus pneumoniae (Spn) colonizes the epithelial surface of the human nasopharynx in
early childhood and remains a significant cause of respiratory illness. Globally, Spn causes 15 million cases of
pneumococcal disease (PD) each year leading to approximately ∼0.5 million deaths in children. Treatment of PD
has been hindered by emergence of antimicrobial resistance, including the resistance to macrolides. Most
pneumococcal macrolide resistance is conferred by Erm(B), the RNA methylase, and/or efflux/ribosomal
protection mediated by Mef(E)/Mel on the macrolide efflux genetic assembly (Mega) element. The Mega
element, related to Tn916 conjugative transposons but does not encode putative recombinases, has integrated
into at least four loci in the pneumococcal chromosome, Mega classes I–IV. Molecular epidemiological studies
demonstrated a higher prevalence of isolates containing the class II Mega, which is not caused by clonal
expansion. Moreover, a wide array of complex Tn916 related mobile genetic elements, termed integrative and
conjugative elements (ICEs), has emerged that also facilitate dissemination of macrolide resistance (both ermB
and Mega) and additional antibiotic resistance markers. While acquisition of Mega and ICE-encoded resistance
presumably occurs during colonization of the human nasopharynx, the efficiency and the specific mechanisms
by which Mega elements and ICEs spread among pneumococci in the nasopharynx is not well understood. Our
novel discovery of pneumococcal unidirectional transformation in the human nasopharyngeal biofilms has
provided new insights on gene transfer in S. pneumoniae. In this proposal, using an established model of
human nasopharyngeal consortial biofilms and the newly characterized uni-directional gene transfer
phenomenon, we will determine the mechanisms and frequencies of macrolide resistance dissemination
mediated by the Mega elements and ICEs. In Aim 1 we will evaluate whether genomic recombination hot spots
or strain background, influence the recombination frequency (rF) and account for different prevalence among
Mega classes. Donor strains engineered with each of the four Mega classes and defined pneumococcal clinical
isolates containing the Mega classes will be conducted to assess the contribution of genomic loci and strain
backgrounds, respectively. Both the rF and the specific recombination sites will be defined in recombinants. In
aim 2 we will investigate whether conjugation or recombination via transformation, drives the mobilization of ICE-
encoded macrolide resistant determinants. The molecular mechanism of ICE-dissemination among
pneumococci will be further investigated using mutants with inactivated transposon-encoded mobilization
proteins and proteins mediating competence. Identifying the horizontal dissemination mechanisms and
frequencies of the two-major macrolide resistance genetic determinants will be valuable for new interventions
aimed at decreasing the burden of antibiotic resistance dissemination in S. pneumoniae.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1128/msphere.01117-20
发表时间:
2020-12-09
期刊:
mSphere
影响因子:
4.8
作者:
[McDevitt E, Khan F, Scasny A, Thompson CD, Eichenbaum Z, McDaniel LS, Vidal JE]
通讯作者:
Vidal JE
DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE
-
批准号:10027021
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2019
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8366095
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8366091
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8366093
-
项目类别:
-
资助金额:$272.54万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE
-
批准号:8366094
-
项目类别:
-
资助金额:$66.74万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8366092
-
项目类别:
-
资助金额:$189.12万
-
财政年份:2011
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173821
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8173819
-
项目类别:
-
资助金额:$227.88万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8173818
-
项目类别:
-
资助金额:$124.79万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173817
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE
-
批准号:8173820
-
项目类别:
-
资助金额:$146.49万
-
财政年份:2010
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (UL1)
-
批准号:7900241
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2009
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (UL1)
-
批准号:7900242
-
项目类别:
-
资助金额:$99.88万
-
财政年份:2009
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:7719800
-
项目类别:
-
资助金额:$64.37万
-
财政年份:2008
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:7719802
-
项目类别:
-
资助金额:$223.82万
-
财政年份:2008
-
负责人:DAVID S STEPHENS
-
依托单位:
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE
-
批准号:7719803
-
项目类别:
-
资助金额:$127.89万
-
财政年份:2008
-
负责人:DAVID S STEPHENS
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:7719801
-
项目类别:
-
资助金额:$127.89万
-
财政年份:2008
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (KL2)
-
批准号:8133799
-
项目类别:
-
资助金额:$59.19万
-
财政年份:2007
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal
-
批准号:8467208
-
项目类别:
-
资助金额:$24.32万
-
财政年份:2007
-
负责人:DAVID S STEPHENS
-
依托单位:
Atlanta Clinical and Translational Science Institute (TL1)
-
批准号:7497160
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2007
-
负责人:DAVID S STEPHENS
-
依托单位:
海外基金